Insider Transactions in Q1 2023 at Spring Works Therapeutics, Inc. (SWTX)
Insider Transaction List (Q1 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 16
2023
|
Jeffrey Lawrence Schwartz Director |
SELL
Open market or private sale
|
Indirect |
1,750,000
-36.22%
|
$49,000,000
$28.5 P/Share
|
Mar 15
2023
|
Julie Hambleton Director |
SELL
Open market or private sale
|
Direct |
1,106
-18.67%
|
$34,286
$31.5 P/Share
|
Jan 26
2023
|
Daniel Pichl Chief People Officer |
SELL
Open market or private sale
|
Direct |
858
-2.38%
|
$26,598
$31.0 P/Share
|
Jan 07
2023
|
Herschel S Weinstein General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
909
-2.47%
|
$23,634
$26.41 P/Share
|
Jan 07
2023
|
L. Mary Smith Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,068
-0.5%
|
$27,768
$26.41 P/Share
|
Jan 07
2023
|
Perier I Francis Jr Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,090
-2.45%
|
$28,340
$26.41 P/Share
|
Jan 07
2023
|
Daniel Pichl Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
546
-1.49%
|
$14,196
$26.41 P/Share
|
Jan 07
2023
|
Badreddin Edris Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,483
-0.62%
|
$38,558
$26.41 P/Share
|
Jan 07
2023
|
Saqib Islam Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,097
-0.45%
|
$106,522
$26.41 P/Share
|
Jan 07
2023
|
Michael Nofi Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
409
-2.37%
|
$10,634
$26.41 P/Share
|
Jan 06
2023
|
Daniel Pichl Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,719
-4.49%
|
$46,413
$27.52 P/Share
|
Jan 06
2023
|
Herschel S Weinstein General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,782
-4.63%
|
$48,114
$27.52 P/Share
|
Jan 06
2023
|
Bhavesh Ashar Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,665
-3.56%
|
$44,955
$27.52 P/Share
|
Jan 06
2023
|
Michael Nofi Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
783
-4.34%
|
$21,141
$27.52 P/Share
|
Jan 06
2023
|
L. Mary Smith Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,452
-1.14%
|
$66,204
$27.52 P/Share
|
Jan 06
2023
|
James Cassidy Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,263
-2.6%
|
$34,101
$27.52 P/Share
|
Jan 06
2023
|
Badreddin Edris Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,326
-1.37%
|
$89,802
$27.52 P/Share
|
Jan 06
2023
|
Saqib Islam Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,400
-0.92%
|
$226,800
$27.52 P/Share
|
Jan 06
2023
|
Perier I Francis Jr Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,374
-5.06%
|
$64,098
$27.52 P/Share
|
Jan 05
2023
|
Daniel Pichl Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,425
+33.64%
|
-
|
Jan 05
2023
|
Herschel S Weinstein General Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
19,425
+33.52%
|
-
|
Jan 05
2023
|
Bhavesh Ashar Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,663
+32.64%
|
-
|
Jan 05
2023
|
Michael Nofi Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,713
+34.99%
|
-
|
Jan 05
2023
|
L. Mary Smith Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,663
+9.51%
|
-
|
Jan 05
2023
|
James Cassidy Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,663
+31.85%
|
-
|
Jan 05
2023
|
Badreddin Edris Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,994
+12.32%
|
-
|
Jan 05
2023
|
Saqib Islam Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
84,175
+8.4%
|
-
|
Jan 05
2023
|
Perier I Francis Jr Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,425
+29.28%
|
-
|